ATR

AptarGroup, Inc.

Healthcare
US companies in Healthcare (47)
NYSE · USD
Mkt cap $8.1bn

$127.07

as of 26 Oct 2026, 14% below its 52-week high

Signals point to elevated dividend-cut risk, though it still screens as reasonably placed to keep growing its dividend.

These scores are a resilience check on the dividend, not a recommendation to buy or sell. They are not financial advice.

Trailing yield: 1.13%Last 12 months of regular payments at today's price
Forward yield: 1.21%Each payment expected in the next 12 months, not the latest one doubled
Earnings cover: 3.0×Pays 34% of earnings
Cash cover: 2.5×Free cash flow over dividends paid
5y dividend growth: +4.9% a yearNo cut since FY2008
Next ex-dividend date: Estimated4 Feb 2027Quarterly dividend of about $0.51

Compared with US companies in Healthcare (47)

Trailing yield is higher than 27 of the 46 other US companies in Healthcare.
5y dividend growth (as paid) is lower than 26 of the 38 other US companies in Healthcare with a 5y growth figure.

Quality

Moderate

Capacity to keep growing the dividend

Risk

High

Signals of dividend-cut pressure

Trim

Low

How extended the valuation looks

Why Risk is 80

ATR against US companies in Healthcare (47)

Valuation against its own history

As of the last reported period (30 Jun 2026). P80 means the figure is higher than 80% of ATR’s past readings.

P/E22.0×P8, good for this measure
Yield1.51%P85, good for this measure
FCF payout39.5%P47, neutral for this measure
Net debt / EBITDA1.50P44, neutral for this measure
DGR 5y+5.3%P62, neutral for this measure
ROIC9.0%P64, neutral for this measure

Open valuation history

Forecast your income with the ATR dividend calculator

Inspect surfaces history; it does not predict the future. Nothing here is financial advice or an instruction to buy or sell. Always do your own research. See the Terms of Service.